Skip to main content
Year archive

Elanix Biotechnologies AG — 2016 filings

All 19 regulatory filings released by Elanix Biotechnologies AG (ELN) in 2016, sourced directly from the official regulator.

19 Filings
2016 Period
2016 filings (19)
Filing Released Lang
Elanix Biotechnologies AG announces non-binding letter of intent with Oxford MEStar Ltd. in regard to setting up a JV to market GynRepair in China
M&A Activity
2016-11-22 English
Elanix Biotechnologies AG: ELANIX BIOTECHNOLOGIES AG STRATEGIC PARTNER, TRANSWELL BIOTECHNOLOGY LTD., RECEIVES US FDA CLEARANCE FOR PHASE I/II CLINICAL TRIAL USING FIBROBLAST PROGENITORS TWB-103
Regulatory Filings
2016-11-08 English
ELANIX BIOTECHNOLOGIES AG, KEY PATENT FOR THE PREPARATION OF PARENTAL CELL BANK GRANTED IN THE U.S.A.
Regulatory Filings
2016-10-25 English
ELANIX BIOTECHNOLOGIES AG subsidiary acquires 100% of equity of Repair-A SA
M&A Activity
2016-09-30 English
Report Publication Announcement 2016
Report Publication Announcement
2016-09-27 English
Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 27.10.2016 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2016-09-20 German
Report Publication Announcement 2016
Report Publication Announcement
2016-09-15 English
Report Publication Announcement 2016
Report Publication Announcement
2016-09-15 English
ELANIX BIOTECHNOLOGIES AG securing funding, adding staff and moving to larger offices
Regulatory Filings
2016-09-01 English
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements
2016-08-19 English
KKR & Co. L.P. Announces Third Quarter 2011 Results
Earnings Release Q3 2011
2016-08-18 English
Elanix Biotechnologies AG: Kapitalerhohung vollstandig platziert
Capital/Financing Update
2016-08-11 German
Elanix Biotechnologies AG beschliet Kapitalerhohung gegen Bareinlagen aus genehmigtem Kapital
Share Issue/Capital Change
2016-07-29 German
Elanix Biotechnologies AG: Vorstand Armin Schulz abberufen
Board/Management Information
2016-06-20 German
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2016-06-07 English
Report Publication Announcement 2016
Report Publication Announcement
2016-04-26 English
Elanix Biotechnologies AG beschliet Kapitalerhohung
Share Issue/Capital Change
2016-04-15 German
Elanix Biotechnologies AG: Erweiterung des Vorstands, Wahl des Aufsichtsratsvorsitzenden
Board/Management Information
2016-02-15 German
Elanix Biotechnologies AG: Neubesetzung des Aufsichtsrates
Board/Management Information
2016-01-04 German